Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

817 pSG5L HA PTEN G129R Citations (2)

Originally described in: Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.
Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR Proc Natl Acad Sci U S A. 1999 Mar 2. 96(5):2110-5.
PubMed Journal

Articles Citing 817 pSG5L HA PTEN G129R

Articles
Nuclear PTEN functions as an essential regulator of SRF-dependent transcription to control smooth muscle differentiation. Horita H, Wysoczynski CL, Walker LA, Moulton KS, Li M, Ostriker A, Tucker R, McKinsey TA, Churchill ME, Nemenoff RA, Weiser-Evans MC. Nat Commun. 2016 Mar 4;7:10830. doi: 10.1038/ncomms10830. PubMed
PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer. Wozniak DJ, Kajdacsy-Balla A, Macias V, Ball-Kell S, Zenner ML, Bie W, Tyner AL. Nat Commun. 2017 Nov 15;8(1):1508. doi: 10.1038/s41467-017-01574-5. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.